191 related articles for article (PubMed ID: 38575607)
1. The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer.
Zhang HR; Li TJ; Yu XJ; Liu C; Wu WD; Ye LY; Jin KZ
Cell Death Dis; 2024 Apr; 15(4):244. PubMed ID: 38575607
[TBL] [Abstract][Full Text] [Related]
2. Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of β-catenin.
Zhou L; Luo M; Cheng LJ; Li RN; Liu B; Linghu H
Pathol Res Pract; 2019 Dec; 215(12):152681. PubMed ID: 31685298
[TBL] [Abstract][Full Text] [Related]
3. GFAT1/HBP/O-GlcNAcylation Axis Regulates
Jia C; Li H; Fu D; Lan Y
Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
[TBL] [Abstract][Full Text] [Related]
4. GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway.
Kroef V; Ruegenberg S; Horn M; Allmeroth K; Ebert L; Bozkus S; Miethe S; Elling U; Schermer B; Baumann U; Denzel MS
Elife; 2022 Mar; 11():. PubMed ID: 35229715
[TBL] [Abstract][Full Text] [Related]
5. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
6.
Zhang W; Bouchard G; Yu A; Shafiq M; Jamali M; Shrager JB; Ayers K; Bakr S; Gentles AJ; Diehn M; Quon A; West RB; Nair V; van de Rijn M; Napel S; Plevritis SK
Cancer Res; 2018 Jul; 78(13):3445-3457. PubMed ID: 29760045
[TBL] [Abstract][Full Text] [Related]
7. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
8. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
9. Targeting PGM3 as a Novel Therapeutic Strategy in
Lee H; Cai F; Kelekar N; Velupally NK; Kim J
Cells; 2022 Jan; 11(1):. PubMed ID: 35011738
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.
Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR
Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer.
Yang S; Li G; Yin X; Wang Y; Jiang X; Bian X; Fang T; Yin S; Zhang L; Xue Y
J Pathol Clin Res; 2023 Sep; 9(5):391-408. PubMed ID: 37395335
[TBL] [Abstract][Full Text] [Related]
12. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2.
Nabeebaccus AA; Verma S; Zoccarato A; Emanuelli G; Santos CX; Streckfuss-Bömeke K; Shah AM
Biochem Biophys Res Commun; 2021 Dec; 583():121-127. PubMed ID: 34735873
[TBL] [Abstract][Full Text] [Related]
14. Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer.
Chao D; Ariake K; Sato S; Ohtsuka H; Takadate T; Ishida M; Masuda K; Maeda S; Miura T; Mitachi K; Yu XJ; Fujishima F; Mizuma M; Nakagawa K; Morikawa T; Kamei T; Unno M
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846782
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Itano N; Iwamoto S
Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
[TBL] [Abstract][Full Text] [Related]
16. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
[TBL] [Abstract][Full Text] [Related]
17. NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer.
Szymura SJ; Zaemes JP; Allison DF; Clift SH; D'Innocenzi JM; Gray LG; McKenna BD; Morris BB; Bekiranov S; LeGallo RD; Jones DR; Mayo MW
Cell Commun Signal; 2019 Mar; 17(1):24. PubMed ID: 30885209
[TBL] [Abstract][Full Text] [Related]
18. Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells.
Li X; Peng X; Zhang C; Bai X; Li Y; Chen G; Guo H; He W; Zhou X; Gou X
Adv Sci (Weinh); 2022 Oct; 9(30):e2202993. PubMed ID: 36045101
[TBL] [Abstract][Full Text] [Related]
19. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
20. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
